Vectora structures the entire LAI ecosystem — every company, drug, candidate and technology — into one source your team can explore, monitor and build on.
So you rebuild it by hand, every time. Vectora maintains it — long-acting injectables as a field of their own, scoped, de-duplicated, and updated as the field moves — so you can put real questions to it, not reassemble it.
Every company, marketed drug, clinical candidate, trademark, proprietary delivery technology, target and indication in the LAI landscape — defined, curated and resolved into one queryable ontology.
Each asset is a molecule × delivery technology × developer. Size the landscape and segment it — by phase, technology, target or modality.
Each product is a brand × authority. Read the real regulatory profile — FDA against EMA, label by label.
One substrate feeds all three products, each unlocked for your organization as it becomes available.
Explore the landscape. Scope a population, compare molecules or products, read FDA against EMA in one view.
A periodic brief of LAI events — readouts, approvals, deals — filtered to the field.
Briefs and reports generated on demand — each claim traceable to its source.
Filter the landscape to the assets you care about, then read it through a lens: a table, a competitive landscape, market trends over time, a positioning map — and a side-by-side comparison, FDA against EMA.
Sourced by default. Regulatory facts link to their official FDA and EMA labels.
The same substrate, read through the lens of each role.
Vectora encodes that domain work — the scope, the ontology, the delivery-technology taxonomy — into the substrate itself. In a specialized field, the analysis is only as strong as the domain knowledge behind it.
You work directly with the analyst who builds and maintains the substrate — not an account manager relaying your questions.
Vectora is opening to a first group of LAI teams as design partners. Tell us about your work and we’ll be in touch.
Request access